Related references
Note: Only part of the references are listed.How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules?
Ole Audun Werner Haabeth et al.
FRONTIERS IN IMMUNOLOGY (2014)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells
Alexandre Corthay et al.
CANCER RESEARCH (2009)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells
ZH Qin et al.
IMMUNITY (2000)
Share Paper
